STARHEALTH · Star Health and Allied Insurance Company Ltd · Insurance (Accident & Health)
STARHEALTH · Star Health and Allied Insurance Company Ltd · Insurance (Accident & Health)
As of 05 Nov close
52-week range
13.2% below 52-week high
52-week range: as of 05 Nov 2026 close.
Price chartDaily closes on the stock page.
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Full signal detail →Fundamentals as of 29 Oct 2026
Revenue (latest Q)
₹4,917 Cr
Revenue YoY
PAT YoY
+12.9%
Operating margin
Revenue, last 5 quarters
P/E (TTM)
P/B
3.2
P/S (TTM)
Not available from data source
Sector P/E
Not available from data source
Dividend yield
Not available from data source
Source: Yahoo Finance, as of 29 Oct 2026
No peer comparison data on file for STARHEALTH.
Promoter
stable
FII
rising 3q
MF
10.27% (-1.66pp)
falling 3q
Insider trades
No insider trades in the last 12 months.
Bulk/block deals
| date | canonicalSymbol | buy quantity | buyer count | deal strength | deal types present |
|---|---|---|---|---|---|
| 2026-09-24 | STARHEALTH | 8298710 | 1 | WEAK | BULK |
News timeline
No related news.
Concalls & investor presentations
AI-generatedKey takeaway: The earnings call for Q1 FY 2027 of Star Health and Allied Insurance Company Limited highlighted significant milestones, including the company's 20th anniversary and its position as the largest retail health insurer in India. Management reported a 19% year-on-year increase in gross return premium, reaching Rs. 4,287 crore, and a 37% rise in Fresh Retail Health GWP to Rs. 730 crore. The underwriting result improved to Rs. 111 crore, marking the fourth consecutive quarter of enhanced core underwriting profitability. The combined insurance service ratio improved to 97%, and profit after tax rose 25% to Rs. 550 crore. Management emphasized a disciplined approach to risk selection and a focus on digital transformation, with proprietary channels contributing over 90% of retail business. The call concluded with management reiterating their commitment to sustainable growth and customer-centric strategies.
Management emphasized strong growth and operational improvements throughout the earnings call.
Sourced from an exchange-filed transcript, dated 05 Aug 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Star Health and Allied Insurance Company Limited, dated July 29, 2026, outlines the company's performance for Q1 FY 2027. Management reported a Gross Written Premium (GWP) of ₹4,287 crore, reflecting a 19% year-on-year increase, with Retail Fresh GWP growing by 37% to ₹730 crore. The Combined Insurance Service Ratio (CISR) was noted at 97.0%, down from 98.7% in Q1 FY26. The underwriting result improved significantly to ₹111 crore from ₹16 crore in the previous year. The presentation emphasized a digital-first approach and a strong agency network, with 8.5 lakh agents contributing to growth. Key financial metrics included a Profit After Tax (PAT) of ₹550 crore, a 25% increase year-on-year, and a Return on Equity (ROE) of 9.5%. The document highlighted strategic priorities such as customer centricity and disciplined portfolio management.
Management highlighted strong growth metrics and improved profitability.
Sourced from an exchange-filed presentation, dated 29 Jul 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The earnings call for Star Health and Allied Insurance Company Limited on April 29, 2026, highlighted a year of strategic recalibration focused on enhancing performance across key operational areas. Management reported a significant improvement in metrics, with fresh retail growth of 38% YoY for Q4 FY26 and a 17% YoY increase in gross written premium (GWP) to Rs. 6,259 crore. The underwriting profit for the quarter rose to Rs. 186 crore, a 200% increase YoY. The company noted a marked improvement in loss ratios, with the retail loss ratio improving to 64.8%. Despite a marked-to-market loss of Rs. 558 crore, the full-year profit after tax increased by 16% YoY to Rs. 911 crore. Management emphasized a focus on quality growth and maintaining leadership in the retail health insurance segment, with a market share of 31.3%. The call concluded with management expressing confidence in their strategic direction and operational execution.
Management emphasized significant improvements in performance metrics and strategic execution.
Sourced from an exchange-filed transcript, dated 05 May 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Star Health and Allied Insurance Company Limited for FY26 reported various key performance indicators and financial metrics. The company achieved a normalized profit after tax of ₹1,222 crores, reflecting a 45% year-on-year increase. Gross written premium (GWP) for FY26 was ₹20,369 crores, up 16% from FY25. The presentation highlighted a loss ratio of 68.2% and an expense ratio of 30.2%, resulting in a combined ratio of 98.4%. The company emphasized its customer-centric approach, with a net promoter score improvement to 62 and a persistency ratio of 99%. Digital channels contributed significantly to growth, with 96% of fresh policies sourced digitally. The presentation also outlined the company's commitment to environmental, social, and governance (ESG) initiatives, including health education and wellness programs. Overall, the document provided a comprehensive overview of the company's performance and strategic focus areas.
Management highlighted strong financial performance and growth initiatives.
Sourced from an exchange-filed presentation, dated 29 Apr 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The investor presentation for Star Health and Allied Insurance Company Limited, dated April 28, 2026, outlines the company's performance for Q4 and FY 2026. Management reported a normalized profit after tax of ₹1,222 crores, reflecting a 45% year-on-year increase. The gross written premium (GWP) for FY 2026 was ₹20,369 crores, a 16% increase from FY 2025. The presentation highlighted key performance indicators, including a loss ratio of 68.2% and an expense ratio of 30.2%. The company emphasized its customer-centric approach, with a net promoter score improvement to 62 and a persistency ratio of 99%. Additionally, management noted the growth in digital channels, with 96% of fresh premiums collected digitally. The presentation also discussed the company's commitment to environmental, social, and governance (ESG) initiatives, including health education and wellness programs.
Management highlighted strong financial performance and growth initiatives.
Sourced from an exchange-filed presentation, dated 28 Apr 2026. Summary is RedixFi-generated and distinct from investment advice.
Key takeaway: The earnings call for Star Health and Allied Insurance Company Limited on January 29, 2026, highlighted the company's strong performance in Q3 FY2026, with a 23% year-on-year increase in gross written premium (GWP) to Rs. 5,047 crore. Management reported a significant rise in IND AS profit after tax (PAT) from Rs. 87 crore in Q3 FY2025 to Rs. 449 crore in Q3 FY2026, alongside an underwriting profit of Rs. 46 crore, a turnaround from a loss of Rs. 79 crore in the previous year. The combined ratio improved to 98.9%, and the loss ratio decreased to 68.8%. The retail health segment grew 33.6%, significantly outpacing overall non-life insurance growth. Management emphasized a focus on maintaining leadership in retail health and highlighted ongoing investments in technology and digital initiatives to enhance customer experience. The call concluded with a Q&A session addressing various operational and financial queries.
Management emphasized strong growth and improved financial metrics during the earnings call.
Sourced from an exchange-filed transcript, dated 03 Feb 2026. Summary is RedixFi-generated and distinct from investment advice.
AI Summary of Annual Report
AI-generatedStar Health and Allied Insurance Company Limited's FY2025-26 annual report highlights its focus on integrated reporting, compliance, and long-term value creation through financial, human, and intellectual capitals. The report indicates no significant regulatory actions, defaults, or liquidity issues, with the company maintaining a going concern status. The company has no pending insolvency proceedings and has strengthened its internal controls and risk management frameworks. It outlines strategic priorities including expanding healthcare access, digital transformation, and enhancing customer experience.
- No significant regulatory actions or defaults reported; no insolvency proceedings pending.
- Maintained going concern status with no material uncertainties noted.
- Strengthened internal controls, risk management, and compliance frameworks.
- Focused on digital transformation, healthcare access expansion, and customer experience enhancement.
- No material audit issues or financial misstatements identified.
Key takeaway: Star Health's FY2025-26 report indicates strong compliance, no major regulatory or financial risks, and a strategic focus on growth and digital transformation, supporting its continued operations as a going concern.
The following annual report excerpts provide qualitative strategic context. Do not treat any specific financial figures in these excerpts as authoritative — they may be incorrectly labeled due to PDF table extraction limitations. For precise financial data, refer to the structured fundamentals data above.
Governance disclosures
AI-generatedNeeds attention
No item of a kind that needs attention was stored for this company.
Contingent Liability
1 occurrenceEarlier (1-3 years ago)
The Company has disputed GST demands amounting to ₹28,813 Lakhs and has pending income tax disputes with demands aggregating to ₹6,268 Lakhs, with the outcome uncertain.
Related-Party Transaction
1 occurrenceEarlier (1-3 years ago)
The company has transactions with related parties including Mr. Anand Roy (Managing Director & CEO), his mother Ms. Jayashree Roy, and his wife Ms. Akila Diwakar Shetty, involving remuneration, insurance premiums, ESOP shares, and asset sales. Other related parties include Pegasus Assets Reconstruction Pvt. Ltd., Expedient Healthcare Marketing Private Limited, and Rare Enterprises, with transactions such as insurance premiums and payment gateway services.